Journal of Biological Chemistry · 2008 · 66 citations · 36 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular Cell BiologyMolecular OncologyApoptosis In CancerApoptosis ResistanceCancer Cell SignalingSignal Transduction In CancerAnti-apoptotic AgentsApoptosis Signaling In CancerBreast Cancer Resistance MechanismsCancer Signaling PathwaysMolecular Drug ResistanceProtein Binding In OncologyProtein Binding MotifYeast Two-hybrid Screening
RACK1 is a 7-WD motif-containing protein with numerous downstream effectors regulating various cellular functions. Using a yeast two-hybrid screen, we identified dynein light chain 1 as a novel interacting partner of RACK1. Additionally, we demonstrated that RACK1 formed a complex with DLC1 and Bim, specifically BimEL, in the presence of apoptotic agents. Upon paclitaxel treatment, RACK1, DLC1, and CIS mediated the degradation of BimEL through the ElonginB/C-Cullin2-CIS ubiquitin-protein isopeptide ligase complex. We further showed that RACK1 conferred paclitaxel resistance to breast cancer cells in vitro and in vivo. Finally, we observed an inverse correlation between CIS and BimEL levels in both ovarian and breast cancer cell lines and specimens. Our study suggests a role of RACK1 in protecting cancer cells from apoptosis by regulating the degradation of BimEL, which together with CIS could play an important role of drug resistance in chemotherapy.
36
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes
Philippe Bouillet, Jared F. Purton, Dale I. Godfrey et al. · Nature · 2002 · 767 citations
A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Martin Dickens, Jeffrey S. Rogers, Julie Cavanagh et al. · Science · 1997 · 678 citations